Table 1.
Patient demographics and clinical characteristics.
| Parameter | Median (% or IQR) | |
|---|---|---|
| Age (years) | 71 (55–83) | |
| Gender | Male | 11 (48%) |
| Female | 12 (52%) | |
| Primary tumor | Colon | 19 (83%) |
| Rectal | 4 (17%) | |
| Grade | 1 | 0 (0%) |
| 2 | 16 (70%) | |
| 3 | 7 (30%) | |
| ECOG | 0 | 16 (70%) |
| 1 | 7 (30%) | |
| 3 | 0 (0%) | |
| Mucinous/Non-mucinous | Mucinous | 7 (30%) |
| Non-mucinous | 16 (70%) | |
| Metastases | Liver only | 8 (35%) |
| Other tissues only | 8 (35%) | |
| Liver and other tissues | 7 (30%) | |
| CEA | 6.7 (3.1–22.5) | |
| CA19.9 | 23 (5.3–108.5) | |
| ALP | 210 (130–268) | |
| LDH | 172 (133–293) |
The median and frequency (%) or interquartile range (IQR) for all parameters are shown.
ECOG, Eastern Cooperative Oncology Group, NCI; CEA, carcinoembryonic antigen; ALP, alkaline phosphatase; LDH, lactate dehydrogenase.